Article info

Download PDFPDF

UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12

Authors

  1. Correspondence to Dr Adnan Tufail, Department of Medical Retina Moorfields Eye Hospital NHS Trust, 162 City Road, London EC1V 2PD, UK; Adnan.Tufail{at}moorfields.nhs.uk
View Full Text

Citation

Lee AY, Lee CS, Butt T on behalf of UK AMD EMR Users Group, et al
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12

Publication history

  • Received October 5, 2014
  • Revised December 11, 2014
  • Accepted January 12, 2015
  • First published February 13, 2015.
Online issue publication 
July 21, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.